{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T11:23:41Z","timestamp":1774524221341,"version":"3.50.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"United States Department of Veterans Affairs Health Services Research & Development","award":["IK2HX001516; PI: T. Lovejoy"],"award-info":[{"award-number":["IK2HX001516; PI: T. Lovejoy"]}]},{"name":"United States Department of Veterans Affairs Health Services Research & Development","award":["IK2HX001516; PI: T. Lovejoy"],"award-info":[{"award-number":["IK2HX001516; PI: T. Lovejoy"]}]},{"name":"United States Department of Veterans Affairs Health Services Research & Development","award":["IK2HX001516; PI: T. Lovejoy"],"award-info":[{"award-number":["IK2HX001516; PI: T. Lovejoy"]}]},{"name":"United States Department of Veterans Affairs Health Services Research & Development","award":["IK2HX001516; PI: T. Lovejoy"],"award-info":[{"award-number":["IK2HX001516; PI: T. Lovejoy"]}]},{"name":"United States Department of Veterans Affairs Health Services Research & Development","award":["IK2HX001516; PI: T. Lovejoy"],"award-info":[{"award-number":["IK2HX001516; PI: T. Lovejoy"]}]},{"name":"United States Department of Veterans Affairs Health Services Research & Development","award":["IK2HX001516; PI: T. Lovejoy"],"award-info":[{"award-number":["IK2HX001516; PI: T. Lovejoy"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Two-thirds of adults in the United States (U.S.) find recreational and medical cannabis use acceptable. Evidence shows that cannabis use is an effective treatment for pain, and as a harm reducing therapeutic for Substance Use Disorder (SUD). In contrast to most SUD treatment models, some models allow illegal substance use as a harm reduction strategy, which is the case for the SUD treatment program examined in this study. Little is known about veterans with SUD and their perspectives on cannabis use to treat pain. This study characterizes veteran perspectives on cannabis use to manage chronic pain, and pain-related anxiety and poor sleep, during treatment for non-cannabis SUD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Thirty-three U.S. military veterans with a diagnosis of chronic pain, who were receiving care from a Veterans Affairs (VA) SUD treatment program were eligible to participate. Patients with polysubstance use could continue to use substances, as long as they committed to a goal of abstaining from the substance that was the primary focus of their SUD treatment. Most patients had a primary diagnosis of alcohol use disorder (70%), followed by opioid use disorder (18%), and stimulant use disorder (12%). Patients with a primary cannabis SUD were excluded. Patients completed a semi-structured interview. Content analysis identified key narrative themes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Approximately one-third of patients reported cannabis use during SUD treatment. Motivations for cannabis use were to alleviate pain, pain-related anxiety and poor sleep quality, and viewing cannabis as a harm reducing therapeutic. Approximately half of patients abstained from cannabis due to negative physical and mental effects experienced in the past, fear of returning to use their primary SUD substance, and to avoid the violation of policies or laws prohibiting cannabis use. Some patients who did not use cannabis showed interest in future cannabis use for pain based on recent cannabis science, laymen\u2019s knowledge and curiosity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Patients with non-cannabis SUD may choose to use cannabis to alleviate chronic pain, pain-related anxiety and poor sleep quality, and as a harm reducing therapeutic during SUD treatment. VA and other federally employed clinicians, particularly in states where cannabis is legal, should prepare to educate patients on the medical evidence, gaps, policies and laws related to cannabis to help patients make more informed healthcare decisions related to cannabis use.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12954-026-01412-2","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T08:24:34Z","timestamp":1771489474000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A qualitative study on cannabis use for harm reduction and pain among veterans enrolled in an SUD treatment program"],"prefix":"10.1186","volume":"23","author":[{"given":"Traben","family":"Pleasant","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Ono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Devan","family":"Kansagara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennette","family":"Lovejoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Travis","family":"Lovejoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Wyse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,19]]},"reference":[{"key":"1412_CR1","unstructured":"Gallup. Support for Legal Marijuana Holds at Record High of 68%. 2021. https:\/\/news.gallup.com\/poll\/356939\/support-legal-marijuana-holds-record-high.aspx. Accessed 3 Jan 2025."},{"issue":"4","key":"1412_CR2","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s11916-023-01101-w","volume":"27","author":"M Hameed","year":"2023","unstructured":"Hameed M, Prasad S, Jain E, Dogrul BN, Al-Oleimat A, Pokhrel B, Chowdhury S, Co EL, Mitra S, Quinonez J, Ruxmohan S. Medical cannabis for chronic nonmalignant pain management. Curr Pain Headache Rep. 2023;27(4):57\u201363.","journal-title":"Curr Pain Headache Rep"},{"issue":"7","key":"1412_CR3","doi-asserted-by":"publisher","first-page":"945","DOI":"10.7326\/M22-0217","volume":"175","author":"KF Boehnke","year":"2022","unstructured":"Boehnke KF, Dean O, Haffajee RL, Hosanagar A. US trends in registration for medical cannabis and reasons for use from 2016 to 2020: an observational study. Ann Intern Med. 2022;175(7):945\u201351.","journal-title":"Ann Intern Med"},{"key":"1412_CR4","unstructured":"STEM. Systematically Testing the Evidence on Marijuana. 2023. https:\/\/www.cannabisevidence.org\/. Accessed March 3, 2024."},{"issue":"2","key":"1412_CR5","first-page":"27","volume":"28","author":"S Chayasirisobhon","year":"2019","unstructured":"Chayasirisobhon S. Cannabis and neuropsychiatric disorders: an updated review. Acta Neurol Taiwan. 2019;28(2):27\u201339.","journal-title":"Acta Neurol Taiwan"},{"issue":"11","key":"1412_CR6","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.3390\/biom10111575","volume":"10","author":"MS Garc\u00eda-Guti\u00e9rrez","year":"2020","unstructured":"Garc\u00eda-Guti\u00e9rrez MS, Navarrete F, Gasparyan A, Austrich-Olivares A, Sala F, Manzanares J. Cannabidiol: a potential new alternative for the treatment of anxiety, depression, and psychotic disorders. Biomolecules. 2020;10(11):1575.","journal-title":"Biomolecules"},{"issue":"1","key":"1412_CR7","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1089\/can.2015.29003.ebr","volume":"1","author":"D Piomelli","year":"2016","unstructured":"Piomelli D, Russo EB. The cannabis sativa versus cannabis indica debate: an interview with Ethan Russo, MD. Cannabis Cannabinoid Res. 2016;1(1):44\u20136.","journal-title":"Cannabis Cannabinoid Res"},{"key":"1412_CR8","unstructured":"National Academies of Sciences, Engineering, and Medicine. Cannabis policy impacts public health and health equity. 2024 Sep 26."},{"issue":"17","key":"1412_CR9","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1001\/jama.2017.11909","volume":"318","author":"MO Bonn-Miller","year":"2017","unstructured":"Bonn-Miller MO, Loflin MJ, Thomas BF, Marcu JP, Hyke T, Vandrey R. Labeling accuracy of Cannabidiol extracts sold online. JAMA. 2017;318(17):1708\u20139.","journal-title":"JAMA"},{"key":"1412_CR10","doi-asserted-by":"publisher","first-page":"102509","DOI":"10.1016\/j.drugpo.2019.07.004","volume":"91","author":"D Hammond","year":"2021","unstructured":"Hammond D. Communicating THC levels and \u2018dose\u2019to consumers: implications for product labelling and packaging of cannabis products in regulated markets. Int J Drug Policy. 2021;91:102509.","journal-title":"Int J Drug Policy"},{"issue":"2","key":"1412_CR11","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1089\/can.2020.0079","volume":"7","author":"DJ Kruger","year":"2022","unstructured":"Kruger DJ, Korach NJ, Kruger JS. Requirements for cannabis product labeling by US state. Cannabis Cannabinoid Res. 2022;7(2):156\u201360.","journal-title":"Cannabis Cannabinoid Res"},{"key":"1412_CR12","unstructured":"Ayers C, Shaw B, Robalino S, Ward R, Yeddala S, Morasco B, Kansagara D. Cannabis for anxiety and mood disorders. The Systematically Testing the Evidence on Marijuana Project; 2025. https:\/\/www.cannabisevidence.org\/evidencesyntheses\/anxiety and mood disorders\/. Accessed 1 Jan, 2026."},{"key":"1412_CR13","unstructured":"Ayers C, Harrod C, Durbin S, Shaw B, Robalino S, Paynter R, Yeddala S, Kansagara D. Cannabis for the management of symptoms of PTSD: a living systematic review. Portland, OR: The Systematically Testing the Evidence on Marijuana Project. 2021; revised December 2022. https:\/\/www.cannabisevidence.org\/evidence-syntheses\/ptsd\/. Accessed 1 Jan, 2026."},{"key":"1412_CR14","unstructured":"Systematic Review: Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain. Content last reviewed August 2025. Effective Health Care Program, Agency for Healthcare Research and Quality, Rockville, MD. https:\/\/effectivehealthcare.ahrq.gov\/products\/plant-based-chronic-pain-treatment\/living-review. Accessed 3 Dec 2025."},{"key":"1412_CR15","doi-asserted-by":"crossref","unstructured":"Cummings H, Ul Haq MZ, Dargham A, Shakeel N, Busse JW, Darzi AJ, Alvarez E. Individuals\u2019 values and preferences regarding medical cannabis for chronic pain: a descriptive qualitative study. J Pain Res. 2024;31:21\u201334.","DOI":"10.2147\/JPR.S432823"},{"issue":"3","key":"1412_CR16","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1097\/j.pain.0000000000002077","volume":"162","author":"JJ Wyse","year":"2021","unstructured":"Wyse JJ, Lovejoy J, Holloway J, Morasco BJ, Dobscha SK, Hagedorn H, Lovejoy TI. Patients\u2019 perceptions of the pathways linking chronic pain with problematic substance use. Pain. 2021;162(3):787\u201393.","journal-title":"Pain"},{"key":"1412_CR17","doi-asserted-by":"publisher","first-page":"108892","DOI":"10.1016\/j.jsat.2022.108892","volume":"143","author":"E Ferguson","year":"2022","unstructured":"Ferguson E, Lewis B, Teitelbaum S, Reisfield G, Robinson M, Boissoneault J. Longitudinal associations between pain and substance use disorder treatment outcomes. J Subst Abuse Treat. 2022;143:108892.","journal-title":"J Subst Abuse Treat"},{"issue":"3","key":"1412_CR18","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1097\/j.pain.0000000000000796","volume":"158","author":"TI Lovejoy","year":"2017","unstructured":"Lovejoy TI, Morasco BJ, Demidenko MI, Meath TH, Frank JW, Dobscha SK. Reasons for discontinuation of long-term opioid therapy in patients with and without substance use disorders. Pain. 2017;158(3):526\u201334.","journal-title":"Pain"},{"issue":"2","key":"1412_CR19","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1151\/ascp08424","volume":"4","author":"SR Savage","year":"2008","unstructured":"Savage SR, Kirsh KL, Passik SD. Challenges in using opioids to treat pain in persons with substance use disorders. Addict Sci Clin Pract. 2008;4(2):4.","journal-title":"Addict Sci Clin Pract"},{"issue":"17","key":"1412_CR20","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1001\/jama.2016.13677","volume":"316","author":"EK Choo","year":"2016","unstructured":"Choo EK, Ewing SW, Lovejoy TI. Opioids out, cannabis in: negotiating the unknowns in patient care for chronic pain. JAMA. 2016;316(17):1763\u20134.","journal-title":"JAMA"},{"key":"1412_CR21","doi-asserted-by":"crossref","unstructured":"Lau NSP, Averill S, Murphy F, Sato S, Murphy S. A safer alternative: cannabis substitution as harm reduction. Drug Alcohol Rev. 2015;34(6):654\u20139.","DOI":"10.1111\/dar.12275"},{"issue":"2","key":"1412_CR22","doi-asserted-by":"publisher","first-page":"e0263583","DOI":"10.1371\/journal.pone.0263583","volume":"17","author":"MC Meacham","year":"2022","unstructured":"Meacham MC, Nobles AL, Tompkins DA, Thrul J. I got a bunch of weed to help me through the withdrawals: naturalistic cannabis use reported in online opioid and opioid recovery community discussion forums. PLoS ONE. 2022;17(2):e0263583.","journal-title":"PLoS ONE"},{"key":"1412_CR23","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.drugalcdep.2014.06.006","volume":"142","author":"M Mojarrad","year":"2014","unstructured":"Mojarrad M, Samet JH, Cheng DM, Winter MR, Saitz R. Marijuana use and achievement of abstinence from alcohol and other drugs among people with substance dependence: a prospective cohort study. Drug Alcohol Depend. 2014;142:91\u20137.","journal-title":"Drug Alcohol Depend"},{"key":"1412_CR24","doi-asserted-by":"crossref","unstructured":"Desai IK, Burke K, Li Y, Ganetsky V, Sugarman OK, Krawczyk N, Feder KA. Use of harm reduction practices by state-licensed specialty substance use treatment programs. J Subst Use Addict Treat. 2025 Apr;29:209711.","DOI":"10.1016\/j.josat.2025.209711"},{"issue":"9","key":"1412_CR25","doi-asserted-by":"publisher","first-page":"e050831","DOI":"10.1136\/bmjopen-2021-050831","volume":"11","author":"L Zeng","year":"2021","unstructured":"Zeng L, Lytvyn L, Wang X, Kithulegoda N, Agterberg S, Shergill Y, Esfahani MA, Heen AF, Agoritsas T, Guyatt GH, Busse JW. Values and preferences towards medical cannabis among people living with chronic pain: a mixed-methods systematic review. BMJ Open. 2021;11(9):e050831.","journal-title":"BMJ Open"},{"issue":"1","key":"1412_CR26","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12954-025-01238-4","volume":"22","author":"BE Pridgen","year":"2025","unstructured":"Pridgen BE, Bontemps AP, Lloyd AR, Wagner WP, Kay ES, Eaton EF, Cropsey KL. US substance use harm reduction efforts: a review of the current state of policy, policy barriers, and recommendations. Harm Reduct J. 2025;22(1):101.","journal-title":"Harm Reduct J"},{"issue":"9","key":"1412_CR27","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1177\/1049732305276687","volume":"15","author":"HF Hsieh","year":"2005","unstructured":"Hsieh HF, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res. 2005;15(9):1277\u201388.","journal-title":"Qual Health Res"},{"key":"1412_CR28","unstructured":"Hersey L. Veterans groups, cannabis businesses laud Trump order for helping ease stigma, reshape public views on medical marijuana. https:\/\/www.stripes.com\/veterans\/2025-12-22\/trump-medical-marijuana-veterans-20176011.html. Accessed 24 Dec, 2025."},{"key":"1412_CR29","doi-asserted-by":"publisher","first-page":"69","DOI":"10.2147\/SAR.S116720","volume":"8","author":"JB Teeters","year":"2017","unstructured":"Teeters JB, Lancaster CL, Brown DG, Back SE. Substance use disorders in military veterans: prevalence and treatment challenges. Subst Abuse Rehabil. 2017;8:69\u201377. https:\/\/doi.org\/10.2147\/SAR.S116720.","journal-title":"Subst Abuse Rehabil"},{"issue":"1","key":"1412_CR30","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1477-7517-6-35","volume":"6","author":"A Reiman","year":"2009","unstructured":"Reiman A. Cannabis as a substitute for alcohol and other drugs. Harm Reduct J. 2009;6(1):35.","journal-title":"Harm Reduct J"},{"issue":"7","key":"1412_CR31","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1080\/03007995.2024.2363945","volume":"40","author":"C Dubois","year":"2024","unstructured":"Dubois C, Danielson EC, Beestrum M, Eurich DT. Medical cannabis and its efficacy\/effectiveness on the management of osteoarthritis pain and function. Curr Med Res Opin. 2024;40(7):1195\u2013202.","journal-title":"Curr Med Res Opin"},{"issue":"1","key":"1412_CR32","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1089\/can.2017.0017","volume":"2","author":"KP Hill","year":"2017","unstructured":"Hill KP, Palastro MD, Johnson B, Ditre JW. Cannabis and pain: a clinical review. Cannabis Cannabinoid Res. 2017;2(1):96\u2013104.","journal-title":"Cannabis Cannabinoid Res"},{"issue":"2","key":"1412_CR33","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1097\/j.pain.0000000000002345","volume":"163","author":"MC Enkema","year":"2022","unstructured":"Enkema MC, Hasin DS, Browne KC, Stohl M, Shmulewitz D, Fink DS, Olfson M, Martins SS, Bohnert KM, Sherman SE, Cerda M. Pain, cannabis use, and physical and mental health indicators among veterans and nonveterans: results from the National epidemiologic survey on alcohol and related Conditions-III. Pain. 2022;163(2):267\u201373.","journal-title":"Pain"},{"key":"1412_CR34","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.addbeh.2017.08.010","volume":"76","author":"AK Davis","year":"2018","unstructured":"Davis AK, Lin LA, Ilgen MA, Bohnert KM. Recent cannabis use among veterans in the united states: results from a National sample. Addict Behav. 2018;76:223\u20138.","journal-title":"Addict Behav"},{"issue":"1","key":"1412_CR35","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1037\/tps0000133","volume":"4","author":"J Metrik","year":"2018","unstructured":"Metrik J, Bassett SS, Aston ER, Jackson KM, Borsari B. Medicinal versus recreational cannabis use among returning veterans. Transl Issues Psychol Sci. 2018;4(1):6.","journal-title":"Transl Issues Psychol Sci"},{"issue":"5","key":"1412_CR36","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.amepre.2017.05.019","volume":"53","author":"EJ Groessl","year":"2017","unstructured":"Groessl EJ, Liu L, Chang DG, Wetherell JL, Bormann JE, Atkinson JH, Baxi S, Schmalzl L. Yoga for military veterans with chronic low back pain: a randomized clinical trial. Am J Prev Med. 2017;53(5):599\u2013608.","journal-title":"Am J Prev Med"},{"issue":"10","key":"1412_CR37","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1097\/AJP.0000000000000518","volume":"33","author":"A Plunkett","year":"2017","unstructured":"Plunkett A, Beltran T, Haley C, Kurihara C, McCoart A, Chen L, Wilkinson I, Cohen SP. Acupuncture for the treatment of chronic pain in the military population: factors associated with treatment outcomes. Clin J Pain. 2017;33(10):939\u201343.","journal-title":"Clin J Pain"},{"issue":"4","key":"1412_CR38","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3390\/pharmacy13040096","volume":"13","author":"ML Doucette","year":"2025","unstructured":"Doucette ML, Fisher E, Chin J, Kitsantas P. Medical cannabis use and healthcare utilization among patients with chronic pain: A causal inference analysis using TMLE. Pharmacy. 2025;13(4):96.","journal-title":"Pharmacy"},{"key":"1412_CR39","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.7326\/M21-4520","volume":"175","author":"MS McDonagh","year":"2022","unstructured":"McDonagh MS, et al. Cannabis-based products for chronic pain: a systematic review. Ann Intern Med. 2022;175:1143\u201353. https:\/\/doi.org\/10.7326\/M21-4520.","journal-title":"Ann Intern Med"},{"key":"1412_CR40","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12954-024-00974-3","volume":"21","author":"SE Duhart Clarke","year":"2024","unstructured":"Duhart Clarke SE, Victor G, Lynch P, et al. Cannabis donation as a harm reduction strategy: a case study. Harm Reduct J. 2024;21:58. https:\/\/doi.org\/10.1186\/s12954-024-00974-3.","journal-title":"Harm Reduct J"},{"key":"1412_CR41","unstructured":"National Academies of Sciences, Division MM. Board on Population Health, Public Health Practice, Committee on the Health Effects of Marijuana, An Evidence Review, Research Agenda. The health effects of cannabis and cannabinoids: the current state of evidence and recommendations for research. 2017."}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-026-01412-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-026-01412-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-026-01412-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T10:46:18Z","timestamp":1774521978000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12954-026-01412-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,19]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1412"],"URL":"https:\/\/doi.org\/10.1186\/s12954-026-01412-2","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,19]]},"assertion":[{"value":"30 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study protocol was reviewed and approved by the VA Portland Health Care System Institutional Review Board (FWA00000517). All patients provided written informed consent to participate.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests in this section.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"66"}}